A Dose-Finding Study of N-Acetylcysteine (NAC) to Prevent Cisplatin-induced Hearing Loss in Children With Cancer
Phase of Trial: Phase I
Latest Information Update: 27 Oct 2016
At a glance
- Drugs Acetylcysteine (Primary)
- Indications Hearing loss
- Focus Pharmacokinetics
- 18 Mar 2016 Planned End Date changed from 1 Aug 2019 to 1 Oct 2019, according to ClinicalTrials.gov record.
- 18 Mar 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
- 11 Jan 2016 Planned End Date changed from 1 Mar 2019 to 1 Aug 2019 as reported by ClinicalTrials.gov record.